Georgia Life Sciences Summit Company Showcase — Applications Now Being Accepted

We are pleased to invite applications for company presentations at the Georgia Life Sciences Summit taking place on August 26-27 at the Sandy Springs Performing Arts Center. This is a unique opportunity for innovative life sciences companies to showcase their work to an audience of more than 300+ investors, industry leaders, researchers, and decision-makers. Presenting companies will benefit from high visibility, presentation feedback from a panel of advisors, targeted networking opportunities, and potential partnerships.


Eligibility

We welcome applications from Georgia-based companies operating in agriculture, biotechnology, pharmaceuticals, diagnostics, digital health, medical devices, and other life sciences sectors. Companies should have a validated proof-of-concept or market-ready prototype, a clear commercialization plan with milestones, and legal ownership of technology.


Presentation Details

The format includes a 3-minute presentation followed by a 2-minute Q&A. The audience will consist of investors, corporate executives, researchers, and media. The application deadline is June 30.


Apply now to secure your spot in this year’s showcase!


For questions, contact Stacey Bowlin at sbowlin@galifesciences.org.

May 13, 2026
Georgia Life Sciences thanks Dr. Marty Makary for his service as Commissioner of the U.S. Food and Drug Administration during a period of significant change across the nation’s health and regulatory agencies.
May 12, 2026
Georgia Life Sciences is pleased to announce Tim Opler as a featured keynote speaker at the 2026 Georgia Life Sciences Summit, taking place August 25-26 at the Sandy Springs Performing Arts Center in Atlanta. A leading voice in biotech investment banking, Tim Opler serves as Managing Director in Stifel’s Global Healthcare Group, where he advises innovative life sciences companies on financing, growth strategy, and market positioning across the healthcare landscape. Tim brings deep insight into the evolving biotech investment environment, emerging industry trends, and the factors shaping the future of life sciences innovation and commercialization. Join us for this timely discussion with one of the industry’s most respected financial leaders as we explore the opportunities and challenges defining the next era of life sciences growth . 
May 5, 2026
New coalition forms to develop a national innovation roadmap to strengthen and extend  America’s global leadership in biotechnology
MORE POSTS